The blend’s constituent compounds are selected for their synergistic activity across the key biological processes underpinning skin and connective tissue research. GHK-Cu contributes its well-documented collagen and elastin synthesis stimulation, extracellular matrix remodeling activity, and broad genomic regulatory influence including antioxidant gene upregulation and anti-inflammatory pathway activation. Its copper-chelating mechanism provides a foundational tissue repair and regeneration component to the formulation.

Complementary peptide constituents within the GLOW formulation address additional mechanistic dimensions of dermal research including angiogenesis and dermal microcirculation, fibroblast proliferation and migration, hyaluronic acid and glycosaminoglycan synthesis regulation, melanocyte activity and pigmentation pathway modulation, and cellular oxidative stress resistance mechanisms. Together, the constituent compounds create a multi-pathway research framework that addresses skin biology at the cellular, extracellular, and genomic levels simultaneously.

The 70mg total formulation weight reflects the blend’s design for extended research protocols requiring sustained compound availability across multiple experimental timepoints. Each vial is manufactured under strict quality controls, independently HPLC-tested, and mass-spectrometry confirmed for the accurate concentration and purity of all constituent compounds. Complete COA documentation available upon request. 

Total Blend Weight: 70 MG
Storage: Lyophilized at −20°C | Reconstitute under sterile conditions

FOR RESEARCH USE ONLY